Generali Sells 35.6% Stake, Diversified Trust Cuts 44.9% While Activist Toms Capital Takes New Position in Target
In Q3, Generali sold 18,630 Target shares, reducing its stake 35.6% to 33,721 shares worth $3.03 million, while Diversified Trust trimmed its position 44.9% to 7,076 shares valued at $635,000. Activist Toms Capital Investment Management also disclosed a significant new stake, highlighting potential operational catalysts.
1. Generali Asset Management SPA SGR Reduces Stake
Generali Asset Management SPA SGR trimmed its position in Target Corporation by 35.6% during the third quarter, disposing of 18,630 shares and retaining 33,721 shares at quarter-end. According to the latest SEC filing, the remaining stake was valued at approximately $3.03 million. This reduction marks one of the more significant single-investor adjustments in the period and reflects a strategic rebalancing by the Milan-based asset manager.
2. Broader Institutional Activity Highlights Confidence Shift
Several leading institutional investors also altered their exposure to Target in recent quarters. Vanguard Group increased its holding by 14.7%, adding 6.6 million shares and bringing its total to 51.4 million shares. State Street Corporation boosted its position by 4.3%, acquiring 1.5 million additional shares for a total of 36.7 million. By contrast, Diversified Trust Co. cut its stake by 44.9%, selling 5,769 shares and ending the quarter with 7,076 shares. Collectively, institutional ownership accounts for nearly 80% of shares outstanding, underscoring the impact of such reallocations on investor sentiment.
3. Earnings Beat and Updated Guidance Drive Analyst Revisions
In its November quarter, Target delivered earnings per share of $1.78, surpassing consensus estimates by $0.07, while reporting revenue of $25.27 billion. Although same-store revenue declined 1.6% year-over-year, net margin held at 3.58% and return on equity reached 22.74%. Management issued full-year 2025 EPS guidance of 7.00 to 8.00, above prior forecasts. Following these results, analysts have adjusted their price targets and ratings: ten maintain Buy recommendations, twenty-two Hold, and four Sell, with the average target now near $102.66. Recent downgrades by Sanford C. Bernstein and Citigroup reflect concerns over retail headwinds, while firms such as Guggenheim retain a positive outlook on long-term value creation.